No matter the keviefuddorain nonsense,these are the levels retail are mostly even at.(so I wouldnt be surprised to see that )
I didnt think INSM would give this opportunity this year,but for the
third time since the company failed and dropped Iplex 3 1/2 years ago is the opportunity so many
wished for just a couple of months ago............to get out even after 3++ years(to 9 years)
When sentiment shifts as it has since the 26 M came onto the scene posts like
numbers of patients worldwide x dose price = a 1000 a share price are of course nonsense.
1 trial failure and the company is a takeover candidate for rights and the money remaining.
1 poster I see understands the mounting position,many here are starry eyed making up nonsense to justify that
They were right all along! ...........Insmed will be huge!
I hope they are right,but before that happens....but , Wall street money will come calling for your money again.
Buy and Hold is the surest way to get burned investing in Biotech stocks
Insmed is now quickly owned from 21% to 45 % by Instituions and insiders.
These are lower numbers on the biotech investment scale(witness many
AMLN bios that had 92-95%. I currently own one such biopharma.
If money comes in, I will follow the smart money.
Right now the smart money is the short interest